Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline patient demographics: Pooled subgroup analysis from two randomized phase 3 studies

被引：0
|
作者：
Papp, Kim [1 ]
Szepietowski, Jacek C. [2 ]
Kircik, Leon [3 ]
Toth, Darryl [4 ]
Eichenfield, Lawrence F. [5 ]
Forman, Seth B. [6 ]
Armstrong, April W. [7 ]
Kuligowski, Michael E. [8 ]
Venturanza, May E. [8 ]
Sun, Kang [8 ]
Simpson, Eric L. [9 ]
机构：
[1] Papp Clin Res & Prob Med Res, Waterloo, ON, Canada
[2] Wroclaw Med Univ, Wroclaw, Poland
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[4] Med Res & Prob Med Res, New York, NY USA
[5] Univ Calif San Diego, La Jolla, CA 92093 USA
[6] ForCare Clin Res, Tampa, FL USA
[7] Univ Southern Calif, Los Angeles, CA 90089 USA
[8] Incyte Corp, Wilmington, DE USA
[9] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27496
引用
收藏
页码：AB149 / AB149
页数：1
相关论文
共 50 条
  • [1] Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Thaci, Diamant
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB160 - AB160
  • [2] Efficacy and safety of ruxolitinib cream for the treatment of vitiligo by patient demographics and baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies
    Rosmarin, David
    Ezzedine, Khaled
    Desai, Seemal R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB50 - AB50
  • [3] Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by anatomic region: Pooled analysis from two randomized phase 3 studies
    Simpson, Eric L.
    Bissonnette, Robert
    Gold, Linda F. Stein
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB53 - AB53
  • [4] Efficacy of ruxolitinib cream in patients with atopic dermatitis who demonstrated partial responses: Pooled analysis from two randomized phase 3 studies
    Simpson, Eric L.
    Kircik, Leon
    Blauvelt, Andrew
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Eichenfield, Lawrence F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB50 - AB50
  • [5] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: pooled analysis of two phase III, randomized, double-blind studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Simpson, E. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E62 - E63
  • [6] SUBGROUP ANALYSIS OF QUALITY OF LIFE AND TREATMENT SATISFACTION BY BASELINE PATIENT CHARACTERISTICS: POOLED RESULTS FROM TWO RANDOMIZED PHASE 3 STUDIES OF RUXOLITINIB CREAM FOR THE TREATMENT OF VITILIGO
    Pandya, A. G.
    van Geel, N.
    Butler, K.
    Bibeau, K.
    Gao, J.
    Ezzedine, K.
    VALUE IN HEALTH, 2022, 25 (07) : S321 - S322
  • [7] Patient-reported outcomes of ruxolitinib cream for the treatment of atopic dermatitis: Pooled results from two phase 3 studies
    Simpson, Eric L.
    Augustin, Matthias
    Thaci, Diamant
    Misery, Laurent
    Silverberg, Jonathan I.
    Armstrong, April W.
    Fuxench, Zelma C. Chiesa
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Papp, Kim
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB178 - AB178
  • [8] Efficacy and safety of ruxolitinib cream among adolescents with atopic dermatitis: Pooled Results from two phase 3 studies
    Eichenfield, Lawrence F.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Paller, Amy S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB158 - AB158
  • [9] Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies
    Blauvelt, Andrew
    Szepietowski, Jacek C.
    Papp, Kim
    Simpson, Eric L.
    Silverberg, Jonathan L.
    Kim, Brian S.
    Kwatra, Shawn G.
    Kuligowski, Micahel E.
    Venturanza, May E.
    Wei, Shaoceng
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (03) : 651 - 653
  • [10] Ruxolitinib cream rapidly decreases pruritus in atopic dermatitis: Pooled results from two phase 3 studies
    Blauvelt, Andrew
    Szepietowski, Jacek C.
    Papp, Kim
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Kim, Brian S.
    Kwatra, Shawn G.
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB121 - AB121
12345